BlackRock’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134K | Buy |
42,275
+2,027
| +5% | +$6.41K | ﹤0.01% | 4699 |
|
|
2025
Q1 | $142K | Sell |
40,248
-348
| -0.9% | -$1.23K | ﹤0.01% | 4628 |
|
|
2024
Q4 | $130K | Buy |
40,596
+116
| +0.3% | +$370 | ﹤0.01% | 4669 |
|
|
2024
Q3 | $149K | Buy |
40,480
+639
| +2% | +$2.35K | ﹤0.01% | 4543 |
|
|
2024
Q2 | $186K | Buy |
39,841
+20,182
| +103% | +$94.3K | ﹤0.01% | 4513 |
|
|
2024
Q1 | $173K | Sell |
19,659
-303
| -2% | -$2.67K | ﹤0.01% | 4563 |
|
|
2023
Q4 | $85.4K | Sell |
19,962
-186
| -0.9% | -$796 | ﹤0.01% | 4772 |
|
|
2023
Q3 | $68.7K | Sell |
20,148
-651
| -3% | -$2.22K | ﹤0.01% | 4873 |
|
|
2023
Q2 | $117K | Sell |
20,799
-651
| -3% | -$3.67K | ﹤0.01% | 4779 |
|
|
2023
Q1 | $104K | Buy |
21,450
+558
| +3% | +$2.7K | ﹤0.01% | 4861 |
|
|
2022
Q4 | $126K | Buy |
20,892
+372
| +2% | +$2.25K | ﹤0.01% | 4886 |
|
|
2022
Q3 | $98K | Sell |
20,520
-2,242
| -10% | -$10.7K | ﹤0.01% | 5091 |
|
|
2022
Q2 | $129K | Sell |
22,762
-312
| -1% | -$1.77K | ﹤0.01% | 5071 |
|
|
2022
Q1 | $164K | Sell |
23,074
-936
| -4% | -$6.65K | ﹤0.01% | 5071 |
|
|
2021
Q4 | $190K | Buy |
24,010
+936
| +4% | +$7.41K | ﹤0.01% | 5043 |
|
|
2021
Q3 | $258K | Sell |
23,074
-2,043
| -8% | -$22.8K | ﹤0.01% | 4862 |
|
|
2021
Q2 | $366K | Buy |
25,117
+1,467
| +6% | +$21.4K | ﹤0.01% | 4697 |
|
|
2021
Q1 | $429K | Buy |
23,650
+18,409
| +351% | +$334K | ﹤0.01% | 4564 |
|
|
2020
Q4 | $101K | Buy |
5,241
+232
| +5% | +$4.47K | ﹤0.01% | 4505 |
|
|
2020
Q3 | $94K | Buy |
+5,009
| New | +$94K | ﹤0.01% | 4423 |
|